NCCN Senior Director Evelyn Handel Zapata is Named a ‘40 Under 40 in Cancer: Emerging Leader’ for Milestone Work Improving Safe Use of Chemotherapy

Newswise — PLYMOUTH MEETING, PA [September 25, 2023] —Evelyn Handel Zapata, PharmD, BCPS, BCOP, Senior Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network® (NCCN®)…

Read more NCCN Senior Director Evelyn Handel Zapata is Named a ‘40 Under 40 in Cancer: Emerging Leader’ for Milestone Work Improving Safe Use of Chemotherapy

NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer, in Collaboration with Fight CRC and Pfizer

Newswise — PLYMOUTH MEETING, PA [August 9, 2023] — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced new grants awarded to improve quality initiatives…

Read more NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer, in Collaboration with Fight CRC and Pfizer

National Comprehensive Cancer Network Names the University of Chicago Medicine Comprehensive Cancer Center as 33rd Member Institution

Newswise — PLYMOUTH MEETING, PA and CHICAGO, IL [April 4, 2023] — The National Comprehensive Cancer Network® (NCCN®) today announced the addition of the University of Chicago Medicine Comprehensive Cancer…

Read more National Comprehensive Cancer Network Names the University of Chicago Medicine Comprehensive Cancer Center as 33rd Member Institution